Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer.
Saved in:
| Title: | Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer. |
|---|---|
| Authors: | Iseas S; Oncology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Sendoya JM; Laboratorio de Terapia Molecular y Celular, Genocan, Fundación Instituto Leloir, IIBBA (CONICET), Buenos Aires, Argentina., Robbio J; Oncology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina.; Unidad de Investigación Traslacional, Laboratorio de Biología Molecular GENUIT, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Coraglio M; Proctology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Kujaruk M; Pathology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Mikolaitis V; Pathology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Rizzolo M; Pathology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Cabanne A; Pathology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Ruiz G; Biomakers Molecular Pathology and Research, Buenos Aires, Argentina., Salanova R; Biomakers Molecular Pathology and Research, Buenos Aires, Argentina., Gualdrini U; Proctology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Méndez G; Oncology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Antelo M; Oncology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Carballido M; Oncology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Rotondaro C; Laboratorio de Terapia Molecular y Celular, Genocan, Fundación Instituto Leloir, IIBBA (CONICET), Buenos Aires, Argentina., Viglino J; Laboratorio de Terapia Molecular y Celular, Genocan, Fundación Instituto Leloir, IIBBA (CONICET), Buenos Aires, Argentina., Eleta M; Imaxe Image Diagnosis Center, Buenos Aires, Argentina., Di Sibio A; Hospital General de Agudos 'Dr.Cosme Argerich', Buenos Aires, Argentina., Podhajcer OL; Laboratorio de Terapia Molecular y Celular, Genocan, Fundación Instituto Leloir, IIBBA (CONICET), Buenos Aires, Argentina., Roca E; Oncology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Llera AS; Laboratorio de Terapia Molecular y Celular, Genocan, Fundación Instituto Leloir, IIBBA (CONICET), Buenos Aires, Argentina., Golubicki M; Oncology Unit, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina.; Unidad de Investigación Traslacional, Laboratorio de Biología Molecular GENUIT, Gastroenterology Hospital 'Dr. Carlos Bonorino Udaondo', Buenos Aires, Argentina., Abba MC; Basic and Applied Immunological Research Center, School of Medical Sciences, National University of La Plata, La Plata, Argentina. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Jan 07; Vol. 11, pp. 801880. Date of Electronic Publication: 2022 Jan 07 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2021.801880 |
